A Study Evaluating the Effect of Filgotinib in Participants With Active Axial Spondyloarthritis

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2023
This study is comparing 200 milligrams (mg) of filgotinib a day with a placebo to see if filgotinib helps to treat Axial Spondyloarthritis (axSpA) and is safe to use. The study will also be comparing 200 mg with 100 mg filgotinib a day to see if the lower dose also helps to treat axSpA.
Epistemonikos ID: 29067e103cab0f8847cc526136a4a62d264c4503
First added on: Feb 19, 2024